91 related articles for article (PubMed ID: 10095426)
1. [Bone matrix production in osteosarcoma].
Schulz A; Loreth B; Battmann A; Knoblauch B; Stahl U; Pollex U; Bohle RM
Verh Dtsch Ges Pathol; 1998; 82():144-53. PubMed ID: 10095426
[TBL] [Abstract][Full Text] [Related]
2. Histological and immunohistochemical diversities, and proliferative activity and grading in osteosarcomas.
Hasegawa T; Hirose T; Seki K; Hizawa K; Ishii S; Wakabayashi J
Cancer Detect Prev; 1997; 21(3):280-7. PubMed ID: 9167046
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical study of osteonectin in various types of osteosarcoma.
Schulz A; Jundt G; Berghäuser KH; Gehron-Robey P; Termine JD
Am J Pathol; 1988 Aug; 132(2):233-8. PubMed ID: 3165250
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the presence of osteocalcin, S-100 protein, and proliferating cell nuclear antigen in cells of various types of osteosarcomas.
Chano T; Matsumoto K; Ishizawa M; Morimoto S; Hukuda S; Okabe H; Kato H; Fujino S
Eur J Histochem; 1996; 40(3):189-98. PubMed ID: 8922947
[TBL] [Abstract][Full Text] [Related]
5. Properties of the stromal cell in giant cell tumor of bone.
Ghert M; Simunovic N; Cowan RW; Colterjohn N; Singh G
Clin Orthop Relat Res; 2007 Jun; 459():8-13. PubMed ID: 17327805
[TBL] [Abstract][Full Text] [Related]
6. Expression of EDA+ and EDB+ fibronectin splice variants in bone.
Kilian O; Dahse R; Alt V; Zardi L; Rosenhahn J; Exner U; Battmann A; Schnettler R; Kosmehl H
Bone; 2004 Dec; 35(6):1334-45. PubMed ID: 15589214
[TBL] [Abstract][Full Text] [Related]
7. Granulocyte-macrophage colony-stimulating factor (GM-CSF) induces the osteoblastic differentiation of the human osteosarcoma cell line SaOS-2.
Postiglione L; Domenico GD; Montagnani S; Spigna GD; Salzano S; Castaldo C; Ramaglia L; Sbordone L; Rossi G
Calcif Tissue Int; 2003 Jan; 72(1):85-97. PubMed ID: 12232677
[TBL] [Abstract][Full Text] [Related]
8. Characterization of osteosarcoma cell lines MG-63, Saos-2 and U-2 OS in comparison to human osteoblasts.
Pautke C; Schieker M; Tischer T; Kolk A; Neth P; Mutschler W; Milz S
Anticancer Res; 2004; 24(6):3743-8. PubMed ID: 15736406
[TBL] [Abstract][Full Text] [Related]
9. Value of immunohistochemical detection of noncollagenous proteins of bone for the diagnosis of bone tumours.
Serra M; Scotlandi K; Sollazzo M; Sarti M; Maurici D; Benini S; Picci P; Bertoni F; Baldini N
Int J Oncol; 1996 Aug; 9(2):257-61. PubMed ID: 21541509
[TBL] [Abstract][Full Text] [Related]
10. [The expression of noncollagenous proteins and the tumor differentiation in oral maxillofacial osteosarcoma].
Li J; He RG
Shanghai Kou Qiang Yi Xue; 2001 Mar; 10(1):39-42. PubMed ID: 14994076
[TBL] [Abstract][Full Text] [Related]
11. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
Fanburg-Smith JC; Bratthauer GL; Miettinen M
Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
[TBL] [Abstract][Full Text] [Related]
12. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases.
Loukopoulos P; O'Brien T; Ghoddusi M; Mungall BA; Robinson WF
Res Vet Sci; 2004 Oct; 77(2):131-41. PubMed ID: 15196903
[TBL] [Abstract][Full Text] [Related]
14. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
El-Badawi ZH; Muhammad EM; Noaman HH
Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
[TBL] [Abstract][Full Text] [Related]
15. Expression of transcription factor Yin Yang 1 in human osteosarcomas.
de Nigris F; Botti C; de Chiara A; Rossiello R; Apice G; Fazioli F; Fiorito C; Sica V; Napoli C
Eur J Cancer; 2006 Oct; 42(15):2420-4. PubMed ID: 16962318
[TBL] [Abstract][Full Text] [Related]
16. Expression of extracellular matrix proteins in adenomatoid odontogenic tumor.
Modolo F; Biz MT; Martins MT; Machado de Sousa SO; de Araújo NS
J Oral Pathol Med; 2010 Mar; 39(3):230-5. PubMed ID: 20070486
[TBL] [Abstract][Full Text] [Related]
17. Expression of osteocalcin and its transcriptional regulators core-binding factor alpha 1 and MSX2 in osteoid-forming tumours.
Hopyan S; Gokgoz N; Bell RS; Andrulis IL; Alman BA; Wunder JS
J Orthop Res; 1999 Sep; 17(5):633-8. PubMed ID: 10569470
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma multidisciplinary approach to the management from the pathologist's perspective.
Raymond AK; Jaffe N
Cancer Treat Res; 2009; 152():63-84. PubMed ID: 20213386
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical examination of cytological differentiation in osteosarcomas.
Kawakami T; Shimizu T; Kimura A; Hasegawa H; Siar CH; Ng KH; Nagatsuka H; Nagai N; Kanda H
Eur J Med Res; 2005 Nov; 10(11):475-9. PubMed ID: 16354601
[TBL] [Abstract][Full Text] [Related]
20. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]